Skip to content

US · XRN · REIT - HEALTHCARE FACILITIES

Chiron Real Estate Inc. (XRN) intrinsic value and stock valuation

$25.47as of 2026-11-21 · Mkt cap 464.01M

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Chiron Real Estate Inc. DCF and intrinsic value

InvestorsCraft values XRN with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from XRN’s statements →

Chiron Real Estate Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Real Estate · REIT - Healthcare Facilities Bethesda, MD 20814 chironre.com

How the business is doing

Fiscal 2012–2025, USD

Revenue
$161M+11.5% 5y CAGRd
20122025
Net income
-$-5.84M
20122025
Free cash flow
-$-8.08M
20122025
Total equity
$530.1M+3% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2012–2025, USD
20252024202320222021
Revenue$161M$138.4M$140.9M$137.2M$115.8M
Operating income$49.4M$32.7M$37.9M$38.7M$37M
Net income-$-5.84M$6.63M$20.6M$19.1M$17.6M
EPSd-$-436.47K$2.51M$7.87M$7.31M$7.25M
Operating cash flow$73.6M$70.1M$68.4M$76.5M$69M
Capital expenditure-$-81.69M-$-95.12M-$-10.05M-$-156.2M-$-201.66M
Free cash flow-$-8.08M-$-25.07M$58.4M-$-79.66M-$-132.69M
Total assets$1.24B$1.26B$1.27B$1.39B$1.26B
Total debt$663.7M$653.6M$624.2M$704.7M$579.9M
Net debt$651.3M$646.8M$622.9M$700.6M$572.6M
Total equity$530.1M$555.9M$605.8M$649.1M$637.6M
Cash and short-term investments$12.5M$6.82M$1.28M$4.02M$7.21M
Income statement
20252024202320222021
Revenue$161M$138.4M$140.9M$137.2M$115.8M
Cost of revenue$150.7M$29.3M$28.1M$25.2M$15.5M
Gross profit$10.3M$109.2M$112.9M$112M$100.3M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$20M$21.1M$16.9M$16.6M$16.5M
Other expenses-$-59.04M$55.4M$58.1M$56.7M$46.9M
Operating expenses-$-39.04M$76.5M$75M$73.3M$63.3M
Cost and expenses$111.7M$105.7M$103.1M$98.5M$78.8M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$44.6M$28.7M$30.9M$25.2M$19.7M
Depreciation and amortization$59M$56.1M$59M$57.7M$47.3M
Ebitda$96.7M$91.5M$111.6M$102.9M$85.4M
Operating income$49.4M$32.7M$37.9M$38.7M$37M
Total other income/expenses, net-$-56.25M-$-25.98M-$-16.13M-$-18.71M-$-18.65M
Income before tax-$-6.88M$6.69M$21.7M$20M$18.3M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-5.84M$6.63M$20.6M$19.1M$17.6M
Weighted average shares outstanding$13.4M$2.64M$2.62M$2.62M$2.43M
Weighted average diluted shares outstanding$13.4M$2.64M$2.62M$2.62M$2.43M
Balance sheet
20252024202320222021
Cash and short-term investments$12.5M$6.82M$1.28M$4.02M$7.21M
Net receivables$7.39M$7.69M$6.96M$8.24M$6.23M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$19.8M$17.4M$14.4M$30.5M$25M
Property, plant and equipment, net$15.7M$7.27M$11M$5.03M$3.81M
Goodwill and intangible assets$52.2M$60M$71.9M$97.2M$93.8M
Long-term investments$1.78M$2.07M$0.00$0.00$0.00
Total non-current assets$1.22B$1.24B$1.25B$1.36B$1.24B
Total assets$1.24B$1.26B$1.27B$1.39B$1.26B
Accounts payable$0.00$16.5M$12.8M$13.8M$10.3M
Short-term debt$0.00$631.7M$585.3M$636.5M$514.6M
Deferred revenue$0.00$6.73M$5.09M$4.44M$0.00
Total current liabilities$0.00$671.5M$619.3M$670.5M$540.6M
Long-term debt$663.7M$21.9M$38.9M$68.2M$65.3M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$712.4M$29.1M$42.6M$73.7M$85.3M
Capital lease obligations$4.94M$7.46M$13M$10.5M$8.13M
Total liabilities$712.4M$700.6M$661.9M$744.2M$625.9M
Common stock$10K$70K$70K$70K$70K
Retained earnings-$-349.96M-$-293.74M-$-238.98M-$-198.71M-$-157.02M
Accumulated other comprehensive income (loss)$0.00$18.6M$25.1M$34.7M-$-6.64M
Total equity$530.1M$555.9M$605.8M$649.1M$637.6M
Total investments$1.78M$2.07M$0.00$0.00$0.00
Total debt$663.7M$653.6M$624.2M$704.7M$579.9M
Net debt$651.3M$646.8M$622.9M$700.6M$572.6M
Cash flow statement
20252024202320222021
Net income-$-5.84M$6.63M$20.6M$20M$18.3M
Depreciation and amortization$59M$56.1M$59M$57.7M$47.3M
Stock-based compensation$0.00$5.1M$4.24M$4.68M$5.81M
Change in working capital$2.35M$1.21M-$-5.69M-$-1.74M-$-3.82M
Accounts receivable$200K-$-1.48M$430K-$-2.97M-$-660K
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$3.17M$2.98M-$-2.02M$4.06M$1.92M
Net cash provided by operating activities$73.6M$70.1M$68.4M$76.5M$69M
Investments in property, plant and equipment-$-81.69M-$-81.67M-$-440K-$-150.93M-$-192.25M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-60.4M-$-45.94M$67.6M-$-137.25M-$-194.66M
Common stock issued$0.00$10.9M$0.00$9.9M$205.5M
Common stock repurchased-$-6M$0.00$0.00$0.00$0.00
Dividends paid-$-58.13M-$-65.69M-$-64.85M-$-64.24M-$-58.32M
Net cash used for financing activities-$-10.26M-$-21.89M-$-143.79M$62.4M$127.7M
Net change in cash$2.79M$2.22M-$-7.73M$1.7M$2.01M
Cash at end of period$12.5M$8.94M$6.72M$14.5M$12.8M
Operating cash flow$73.6M$70.1M$68.4M$76.5M$69M
Capital expenditure-$-81.69M-$-95.12M-$-10.05M-$-156.2M-$-201.66M
Free cash flow-$-8.08M-$-25.07M$58.4M-$-79.66M-$-132.69M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Chiron Real Estate Inc.

        Global Medical REIT, Inc. focuses on acquiring specialized healthcare properties designed for medical purposes, subsequently renting them out to medical systems and physician practices. The company was established on March 18, 2011, and operates primarily from its headquarters in Bethesda, Maryland.

        CEO
        Mark O. Decker Jr.
        Employees
        30
        Beta
        1.12

        Explore

        Frequently asked questions

        What is the intrinsic value of Chiron Real Estate Inc. (XRN)?

        Chiron Real Estate Inc. (XRN) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is XRN undervalued?

        XRN trades at a price of $25.47 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.